The Problems with High Dose Pancreatic Enzyme Preparations Christopher J. Taylor Leading Article 26 October 2012 Pages: 75 - 79
Adverse Effects of Direct-Acting Vasodilators Pedro ArmarioRaquel Hernandez del ReyHelios Pardell Review Article 26 October 2012 Pages: 80 - 85
A Risk-Benefit Assessment of Carvedilol in the Treatment of Cardiovascular Disorders William J. LouisHenry KrumElizabeth L. Conway Review Article 26 October 2012 Pages: 86 - 93
A Risk-Benefit Assessment of Drugs Used in the Management of Parkinson’s Disease Ibrahim Y. O. BodaghDorothy R. C. Robertson Review Article 26 October 2012 Pages: 94 - 103
A Risk Benefit Assessment of Drugs Used in the Treatment of Endometriosis Robert W. Shaw Review Article 26 October 2012 Pages: 104 - 113
The Role of Active Metabolites in Drug Toxicity Munir PirmohamedNeil R. KitteringhamB. Kevin Park Review Article 26 October 2012 Pages: 114 - 144